183 related articles for article (PubMed ID: 36275905)
1. Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-
Tao JH; Liu T; Zhang CY; Zu C; Yang HH; Liu YB; Yang JT; Zhou Y; Guan CX
Oxid Med Cell Longev; 2022; 2022():7265486. PubMed ID: 36275905
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
3. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis.
Kim HS; Moon SJ; Lee SE; Hwang GW; Yoo HJ; Song JW
Exp Mol Med; 2021 May; 53(5):864-874. PubMed ID: 33990688
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
5. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells
Zhang CY; Guan XX; Song ZH; Jiang HL; Liu YB; Chen P; Duan JX; Zhou Y
Oxid Med Cell Longev; 2022; 2022():5759626. PubMed ID: 35509835
[TBL] [Abstract][Full Text] [Related]
6. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
7. CYP2J2
Tao P; Jiang Y; Wang H; Gao G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
[TBL] [Abstract][Full Text] [Related]
8. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
[TBL] [Abstract][Full Text] [Related]
10. EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells.
Feng W; Xu X; Zhao G; Li G; Liu T; Zhao J; Dong R; Wang DW; Tu L
Int J Mol Med; 2013 Sep; 32(3):685-93. PubMed ID: 23835530
[TBL] [Abstract][Full Text] [Related]
11. COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence.
Zhang CY; Duan JX; Yang HH; Sun CC; Zhong WJ; Tao JH; Guan XX; Jiang HL; Hammock BD; Hwang SH; Zhou Y; Guan CX
FEBS J; 2020 Apr; 287(8):1666-1680. PubMed ID: 31646730
[TBL] [Abstract][Full Text] [Related]
12. CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
Zhou C; Huang J; Chen J; Lai J; Zhu F; Xu X; Wang DW
Cell Physiol Biochem; 2016; 39(2):721-39. PubMed ID: 27459385
[TBL] [Abstract][Full Text] [Related]
13. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition.
Lu GX; Bian DF; Ji Y; Guo JM; Wei ZF; Jiang SD; Xia YF; Dai Y
Phytother Res; 2014 Aug; 28(8):1224-31. PubMed ID: 24458872
[TBL] [Abstract][Full Text] [Related]
14. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
Zhang Q; Ye W; Liu Y; Niu D; Zhao X; Li G; Qu Y; Zhao Z
Biomed Pharmacother; 2023 Jan; 157():114018. PubMed ID: 36410121
[TBL] [Abstract][Full Text] [Related]
15. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
[TBL] [Abstract][Full Text] [Related]
16. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARγ.
Kim DH; Vanella L; Inoue K; Burgess A; Gotlinger K; Manthati VL; Koduru SR; Zeldin DC; Falck JR; Schwartzman ML; Abraham NG
Stem Cells Dev; 2010 Dec; 19(12):1863-73. PubMed ID: 20412023
[TBL] [Abstract][Full Text] [Related]
18. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
19. Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner.
Zhang R; Liang H; Liu G; Jiang W; Tang Z; Fan Q; Nie Z; Hu H; Kang G; Xie S
Int Immunopharmacol; 2023 Jul; 120():110369. PubMed ID: 37224650
[TBL] [Abstract][Full Text] [Related]
20. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
